1. Home
  2. TIPT vs OCS Comparison

TIPT vs OCS Comparison

Compare TIPT & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiptree Inc.

TIPT

Tiptree Inc.

SELL

Current Price

$17.33

Market Cap

672.9M

Sector

Finance

ML Signal

SELL

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$7.61

Market Cap

732.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIPT
OCS
Founded
2007
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.9M
732.4M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
TIPT
OCS
Price
$17.33
$7.61
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $36.73
AVG Volume (30 Days)
226.7K
★ 272.4K
Earning Date
10-30-2026
11-03-2026
Dividend Yield
★ 1.38%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.34
N/A
Revenue
★ $488,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$365.20
P/E Ratio
$51.06
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$15.49
$7.85
52 Week High
$19.33
$34.48

Technical Indicators

Market Signals
Indicator
TIPT
OCS
Relative Strength Index (RSI) 47.38 21.73
Support Level $17.36 N/A
Resistance Level $17.56 $13.49
Average True Range (ATR) 0.33 0.47
MACD 0.04 -0.05
Stochastic Oscillator 77.99 11.81

Price Performance

Historical Comparison
TIPT
OCS

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: